Source comparison
How Long Does BPC-157 Take to Work in Research: Dosing Comparison
Gastric ulcer (ethanol-induced) 10 µg/kg twice daily Intraperitoneal or oral 24–48 hours (mucosal integrity) 72 hours (complete re-epithelialization) Life Sciences 2019 Achilles tendon transection Subcutaneous at injury site No difference at day 3 Day 14 (85%
This comparison does not assign a generated winner or score.
- Gastric ulcer (ethanol-induced)
- 10 µg/kg twice daily
- Intraperitoneal or oral
- 24–48 hours (mucosal integrity)
- 72 hours (complete re-epithelialization)
- Life Sciences 2019
- Achilles tendon transection
- Subcutaneous at injury site
- No difference at day 3
- Day 14 (85% tensile strength recovery)
- J Appl Physiol 2016
- Muscle crush injury
- 10 µg/kg once daily
- Intramuscular
- 48 hours (reduced creatine kinase)
- Day 10 (normalized grip strength)
- Regul Pept 2014
- Ligament injury (MCL)
- Intraperitoneal
- Day 7 (increased collagen type I)
- Day 14 (improved biomechanical strength)
- Knee Surg Relat Res 2017
- Bone fracture healing
- Subcutaneous near fracture
- Day 7 (increased callus formation)
- Day 21 (radiographic union)
- Bone 2018
- Professional Assessment
- Standard research dose is 10 µg/kg. Higher doses (up to 100 µg/kg) show no additional benefit in most models. Twice-daily dosing outperforms once-daily in injury models with high metabolic turnover (tendon, ligament). Route matters: subcutaneous at injury site for localized repair, intraperitoneal for systemic effects.